Delivery Order 36C25221D0074-36C25226N0079
- Not listed
- CareDx, Inc. has been awarded a delivery order valued at $491,742.36 by the Department of Veterans Affairs through Veterans Integrated Service Network 9 (VISN 9) for genetic blood testing services for transplant patients. The contract, which carries a firm fixed-price structure with no set-aside designation, will be performed in Brisbane, California and is scheduled for completion by September 22, 2026. This delivery order falls under CareDx's larger Indefinite Delivery Contract with VISN 9,...
- Caredx, Inc., a Brisbane, California-based medical technology company specializing in advanced diagnostic solutions for organ transplant patients, was awarded a delivery order valued at $142,037.50 by Veterans Integrated Service Network (VISN) 23 on January 15, 2026. The contract, which carries an ultimate completion date of January 14, 2028, is for AlloSure in-home patient testing services and operates under firm fixed pricing without a set-aside designation. The work will be performed in...
- CareDx, Inc. was awarded a $247,578.50 firm fixed price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 6 on October 19, 2022, for AlloSure kidney donor-derived cell-free DNA testing kits. The contract, which carries no set-aside designation, has an ultimate completion date of October 18, 2027, and is performed in Brisbane, California. The solicitation sought quotes for AlloSure Kidney Donor-Derived Cell-Free DNA Testing services to support the...
- The federal contract award is for laboratory services provided by Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract, valued at $241,463.75, was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx for the delivery of advanced genetic and molecular testing solutions focused on organ transplant diagnostics. The contract, which has a completion date of January 14, 2026, is a Firm Fixed Price Delivery Order, with no set-aside...
- CareDx Lab Solutions Inc., headquartered in West Chester, Pennsylvania, was awarded a delivery order valued at $23,972.68 by the Department of Veterans Affairs Veterans Integrated Service Network 17 (VISN 17) on June 3, 2024. This firm fixed-price contract, which carries no set-aside designation, represents a delivery order issued against an existing single-award indefinite delivery contract valued at $787,000 with an ultimate completion date of June 2, 2027. The delivery order calls for the...
- Caredx, Inc., a medical technology company specializing in advanced diagnostic solutions for organ transplant patients, received a purchase order valued at $66,908.60 from the Veterans Integrated Service Network 17 (VISN 17) on December 15, 2023. The contract, which carries a firm fixed price structure with no set-aside designation, covers AlloSure kidney tests, AlloSure heart tests, and AlloMap heart tests. Performance is scheduled for completion by June 14, 2024, with services to be...
- This is a $193,171.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract is for laboratory reference testing services, specifically Caredx's specialized diagnostic solutions for organ transplant patients, including its AlloMap and AlloSure genetic and molecular testing products. The contract has an ultimate completion date of January 14,...
- This federal contract award is for the delivery of TRANSPLANT TESTING KITS to the Veterans Integrated Service Network 12 (VISN 12), a division of the U.S. Department of Veterans Affairs (VA). The $849,384.25 fixed-price contract with economic price adjustment was awarded on September 30, 2025 to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California. The contract does not have a set-aside designation and has a period of performance through February 28,...
- The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
- This federal contract award is for the provision of genetic blood testing services for transplant patients, specifically the AlloMap and AlloSure testing products, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Caredx, Inc., a for-profit medical technology company headquartered in Brisbane, California, that specializes in advanced diagnostic solutions for organ transplant patients. The contract has a ceiling value of $643,166.71 and is a Firm Fixed Price Delivery...
- 36C25221D0074Indefinite Delivery Contract
- 36C25221D0074-36C25226N0079Delivery Order
CareDx, Inc., a medical technology company headquartered in Brisbane, California, received a delivery order award from the Department of Veterans Affairs Veterans Integrated Service Network 12 (VISN 12) on February 1, 2026, for transplant testing kits. This firm fixed-price delivery order has a ceiling value of $1.6 million with an ultimate completion date of January 31, 2027. The contract represents a continuation of the VA's reliance on CareDx's specialized diagnostic solutions for organ transplant patients, specifically leveraging the company's proprietary AlloSure and AlloMap testing platforms designed to assess organ rejection risks and support post-transplant monitoring for veteran populations. The award carries no set-aside designation and performance will occur at CareDx's facility in Brisbane, California. This delivery order falls under CareDx's broader portfolio of federal contracts with the VA, which currently includes four active Indefinite Delivery Contracts across multiple VISNs with combined values exceeding $11 million. CareDx has established itself as a primary provider of transplant diagnostic services to the federal government, with sustained funding from the Department of Veterans Affairs across multiple regional networks, as well as contracts with the National Institutes of Health Clinical Center, Centers for Disease Control and Prevention, and the Navy Bureau of Medicine and Surgery. The firm fixed-price delivery order structure and the company's extensive contracting history with VISN 12 demonstrate the VA's sustained confidence in CareDx's capability to deliver critical diagnostic capabilities to veteran transplant recipients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6m | 1/22/26 |